Routine cholecystectomy during laparoscopic biliopancreatic diversion with duodenal switch is not necessary

Surgery for Obesity and Related Diseases

Volumn 3, Issue 5, 2007, Pages 549-553

  Bardaro, Sergio Jose ^a,b   Gagner, Michel ^a,b   Consten, Esther ^a,b   Inabnet, William Barry ^a,c   Herron, Daniel ^d   Dakin, Gregory ^a,b   Pomp, Alfons ^a,b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Bariatric surgery; Biliopancreatic diversion with duodenal switch; Cholecystectomy; Gallbladder disease; Gallstone formation; Ursodeoxycholic acid

Indexed keywords

URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; BILIOPANCREATIC BYPASS; CHOLECYSTECTOMY; CHOLECYSTITIS; COLIC; CONTROLLED STUDY; DEMOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; GALLBLADDER DISEASE; GALLSTONE; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT INFORMATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT INDICATION; WEIGHT REDUCTION;

ADULT; BILIOPANCREATIC DIVERSION; CHOLECYSTECTOMY; CHOLECYSTITIS; DUODENUM; FEMALE; FOLLOW-UP STUDIES; GALLSTONES; HUMANS; INCIDENCE; LAPAROSCOPY; MALE; POSTOPERATIVE CARE; RETROSPECTIVE STUDIES; UNNECESSARY PROCEDURES; URSODEOXYCHOLIC ACID;

EID: 34548827695     PISSN: 15507289     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soard.2007.05.007     Document Type: Article

References (23)

1. Shiffman M.L., Sugerman H.J., Kellum J.H., Brewer W.H., and Moore E.W. Gallstones in patients with morbid obesity: relationship to body weight, weight loss and gallbladder bile cholesterol solubility. Int J Obes Relat Metab Disord 17 (1993) 153-158
2. Shiffman M.L., Sugerman H.J., Kellum J.M., Brewer W.H., and Moore E.W. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 86 (1991) 1000-1005
3. Wattchow D.A., Hall J.C., Whiting M.J., Bradley B., Iannos J., and Watts J.M. Prevalence and treatment of gall stones after gastric bypass surgery for morbid obesity. BMJ (Clin Res Ed) 286 (1983) 763
4. Wudel Jr. L.J., Wright J.K., Debelak J.P., Allos T.M., Shyr Y., and Chapman W.C. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res 102 (2002) 50-56
5. Sugerman H.J., Brewer W.H., Shiffman M., et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodeoxycholic acid for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg 169 (1995) 91-97
6. Amaral J.F., and Thompson W.R. Gallbladder disease in the morbidly obese. Am J Surg 149 (1985) 551-557
7. Hamad G.G., Ikramuddin S., Gourash W.F., and Schauer P.R. Elective cholecystectomy during laparoscopic Roux-en-Y gastric bypass: is it worth the wait?. Obes Surg 13 (2003) 76-81
8. Villegas L., Schneider B., Provost D., et al. Is routine cholecystectomy required during laparoscopic gastric bypass?. Obes Surg 14 (2004) 206-211
9. Marinari G.M., Murelli F., Camerini G., et al. A 15-year evaluation of biliopancreatic diversion according to the Bariatric Analysis Reporting Outcome System (BAROS). Obes Surg 14 (2004) 325-328
10. Scopinaro N., Marinari G.M., and Camerini G. Laparoscopic standard biliopancreatic diversion: technique and preliminary results. Obes Surg 12 (2002) 362-365
11. Ren C.J., Patterson E., and Gagner M. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg 10 (2000) 514-523
12. Scopinaro N., Gianetta E., Civalleri D., Bonalumi U., and Bachi V. Two years' experience with bilio-pancreatic bypass. Am J Clin Nutr 33 (1980) 506-514
13. Mason E.E., and Renquist K.E. Gallbladder management in obesity surgery. Obes Surg 12 (2002) 222-229
14. Paiva D., Bernardes L., and Suretti L. Laparoscopic biliopancreatic diversion: technique and initial results. Obes Surg 12 (2002) 358-361
15. Ammori B.J., Vezakis A., Davides D., Martin I.G., Larvin M., and McMahon M.J. Laparoscopic cholecystectomy in morbidly obese patients. Surg Endosc 15 (2001) 1336-1339
16. Sperlongano P., Pisaniello D., Parmeggiani D., De Falco M., Agresti M., and Parmeggiani U. Laparoscopic cholecystectomy in the morbidly obese. Chir Ital 54 (2002) 363-366
17. Deitel M., and Petrov I. Incidence of symptomatic gallstones after bariatric operations. Surg Gynecol Obstet 164 (1987) 549-552
18. Iglezias Brandao de Oliveira C., Chaim E.A., and Borges da Silva B. Impact of rapid weight reduction on risk of cholelithiasis after bariatric surgery. Obes Surg 13 (2003) 625-628
19. Oria H.E. Pitfalls in the diagnosis of gallbladder disease in clinically severe obesity. Obes Surg 8 (2004) 444-451
20. Bajardi G., Ricevuto G., Mastrandrea G., et al. Prophylactic cholecystectomy in bariatric surgery. Minerva Chir 48 (1993) 277-279
21. Herbst C.A., Mittelstaedt C.A., Staab E.V., and Buckwalter J.A. Intraoperative ultrasonography evaluation of the gallbladder in morbidly obese patients. Ann Surg 200 (1984) 691-692
22. Worobetz L.J., Inglis F.G., and Shaffer E.A. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol 88 (1993) 1705-1710
23. Shiffman M.L., Vickers F.F., Stifler L.T.P., et al. A multicenter, double-blind, placebo controlled trial of ursodeoxycholic acid (urso) for prevention of gallstone (GS) formation in obese patients during very low calorie (VLC) dietary induced weight reduction. Gastroenterology 106 (1994) 982